Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine for intermittent preventive treatment of malaria in HIV-positive pregnant women
PACTR2010020001813440Unknown
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Randomised, double-blind trial in malaria comparing Mefloquine with Placebo (2 arms). Primary endpoint: Peripheral parasitemia at delivery. Status: unknown.
02
Drugs
mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR2010020001813440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2010020001813440.